This article available in Chinese version only

CALL輪變價內 點解要轉倉?

2022-06-23

科技股板塊上周表現平平,重磅股騰訊(0700)及阿里(9988)等現較顯著調整,惟京東(9618)周五逆市向上,全周計仍錄得逾4%的升幅,並已連續第三周向上。上周為京東「618」購物節,大行對「618」促銷活動看法正面,上調對京東「618」商品交易總額,最樂觀預測至3888億元人民幣,按年增長最多13%,重申「買入」評級。

 

京東股價水漲船高,由6月初重上220元後動力增加,近日收復100天線,再上試260元的阻力區。市場上京東的窩輪產品中,我們發行的認購證有不少已由價外變為價內,個別更變成深入價內,以12614為例,今年9月到期,行使價207.891,截至周五價內程度已有兩成,輪價收報0.66元,而當京東股價於5月尾時為200元以下之際,當時該認購證尚為輕微價外,價格約為0.27元,即是說該證不消一個月已升逾倍,深入價內。另外分別於237(9月到期)250元附近(11月到期)的兩隻認購證亦同樣變為價內,價格已升至四毫多及五毫多。

 

投資者或會問,既然已變為價內,不如將它當成正股坐到結算?為何要採取轉倉的策略?

 

要解答這個問題,首先投資者要先問自己,入場買窩輪的原意是甚麼。舉例說,投資者買入一隻價外,即行使價高於正股現價的認購證看好正股時,該投資者只付出時間值,過了若干時間及消耗時間值後,當正股發力向上,股價升至高於正股現價時(假設股息為零),即是說一隻窩輪已由價外變為價內,投資者便開始賺取價內值。

 

因此,當正股升至目標價後,投資者不妨考慮「見好即收」,趁有內在值時,先沽出鎖定利潤,再將部分利潤轉倉至價外或貼價之選,以時間值再換取賺內在值的機會,繼續參與正股上升機會。若股價出現掉頭向下,損失亦只是時間值,早前獲利的內在值仍能「袋袋平安」。

Hot topics
Back to Hot topics
本結構性產品並無抵押品,如發行人無力償債或違約,投資者可能無法收回部份或全部應收款項。

本文由香港上海匯豐銀行有限公司(「本行」或「發行商」)發行(包括任何參考條款),僅供參考之用,並不構成邀約、游說、或建議出售或購買結構性產品。

結構性產品屬複雜產品,投資者務須就此審慎行事,除非投資者完全了解及願意承擔所涉風險,否則切勿投資此產品。結構性產品價格可急升可急跌,投資者或會損失所有或大部分投資。過往表現並不反映將來表現。投資前應了解結構性產品之性質及風險,並詳閱有關上市文件,獨立決定是否適合自己,若需要應諮詢專業建議。本行及其委任之流通量提供者可能是結構性產品的唯一市場參與者,而結構性產品的二級市場可能有限。謹請注意,牛熊證設有強制收回機制,因此有可能提早終止,在此情況下(i)N類牛熊證投資者會損失於牛熊證的全部投資;而(ii)R類牛熊證之剩餘價值則可能為零。買賣與美國指數掛鈎的結構性產品可能帶有額外風險,包括:(a)與交易日和交易時間差異有關的風險;(b) 有關指數的公開資料較少,或未有提供中文版本;(c) 與指數有關的政治和經濟風險(例如美國);(d) 匯率風險; (e) 可能延遲結算及(f) 在成份股並無交易時公佈指數水平與MSCI中國A50互聯互通指數掛鈎的衍生權證投資者可能會承受額外風險,包括:(i) 新推出指數的風險;(ii) 指數成份股為透過滬港通及/或深港通在滬港通及深港通的北向交易渠道買賣的A股;(iii) 有關指數的公開資料較少,且該等資料或未有提供中文版本;(iv) 與指數有關的政治及經濟風險;(v) 匯率風險;及(vi) 人民幣利率風險。

作者為金管局及證監會持牌人士,並無就結構性產品或相關資產持有任何直接或間接權益。
Sign up to our newsletter

Stay abreast of the trends with the latest investment insight and market updates.

Latest article

(Available in Chinese only)
Back to Hot topics

Important Risk Warning

The structured products are not collateralized. If the issuer is insolvent or defaults, investors may not recover part or all of the amount due.

Structured products are complex products. Investors should exercise caution in relation to them. The price of the structured products may fall in value as rapidly as it may rise and investors may sustain a total or substantial loss of their investment. Prospective investors should ensure that they understand the nature and risks and seek professional advice where applicable. Please also note that CBBCs have a mandatory call feature and may therefore be subject to early termination, upon which (i) investors in category N CBBCs will lose all of their investments in the CBBCs; and (ii) the residual value of category R CBBCs may be zero. Inline warrants have been newly introduced to the market and there are no similar products currently listed on the Stock Exchange of Hong Kong Limited for comparison. Inline warrants carry exotic features, and their terms and pricing may be more complicated than standard derivative warrants. Maximum potential payoff is fixed and capped. Price movement of the inline warrants may be disproportionate or opposite to the price movement of the underlying asset. Trading structured products with United States (US) underlying index may be exposed to additional risks, including (a) risks relating to difference in trading days and hours, (b) less public information about the index and such information may not be available in Chinese, (c) political and economic risks relating to the index regions (such as the US), (d) exchange rate risks, (e) possible delay in settlement, and (f) publication of index level when component shares are not trading. Investors in derivative warrants linked to the MSCI China A 50 Connect Index may be exposed to additional risks, including (i) risk for newly launched index, (ii) the index constituents are A-shares traded under the Northbound Stock Connect channel through Shanghai-Hong Kong Stock Connect and/or Shenzhen-Hong Kong Stock Connect, (iii) less public information about the index and such information may not be available in Chinese, (iv) political and economic risks relating to the index, (v) exchange rate risks, and (vi) Renminbi interest rate risks. Click here for "Terms of Use".

Disclaimer

By viewing this website or using any information or functions of this website, you are deemed to acknowledge that you agree to the Privacy and Security, Terms of Use and Hyperlink Policy. Click here for "Disclaimer".

All data/charts are for reference purposes only.